Non-treatment-related chronic myeloid leukemia as a second malignancy

Leukemia Research

Volumn 28, Issue 2, 2004, Pages 115-119

  Specchia, Giorgina ^a,b   Buquicchio, Caterina ^a   Albano, Francesco ^a   Liso, Arcangelo ^a   Pannunzio, Alessandra ^a   Mestice, Anna ^a   Rizzi, Rita ^a   Pastore, Domenico ^a   Liso, Vincenzo ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Chronic myeloid leukemia; Non treatment related chronic myeloid leukemia; Second malignancy

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; HEMATOLOGIC MALIGNANCY; HUMAN; MAJOR CLINICAL STUDY; MEDLINE; ONSET AGE; PRIORITY JOURNAL; SCREENING; SECOND CANCER;

EID: 0344844591     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(03)00182-6     Document Type: Article

References (81)

1. Dann E.J., Rowe J.M. Biology and therapy of secondary leukaemias. Bailliere's Best Pract. Res. Clin. Haematol. 14:2001;119.
2. Bokemeyer C., Schmoll H.J. Treatment of testicular cancer and the development of secondary malignancies. J. Clin. Oncol. 13:1995;283.
3. Wolden S.L., Lambom K.R., Cleary S.F., Tate D.J., Donaldson S.S. Second cancers following pediatric Hodgkin's disease. J. Clin. Oncol. 16:1998;536.
4. Tucker M., Coleman C., Cox R., Varghese A., Rosenberg S. Risk of second cancers after treatment for Hodgkin's disease. N. Engl. J. Med. 318:1988;76.
5. Waller C.F., Fetscher S., Lange W. Treatment-related chronic myelogenous leukemia. Ann. Hematol. 78:1999;341.
6. Whang-Peng J., Young R.C., Lee E.C., Longo D.L., Schechter G.P., DeVita V.T. Jr. Cytogenetic studies in patients with secondary leukemia/ dysmyelopoietic syndrome after different treatment modalities. Blood. 71:1988;403.
7. Whang-Peng J., Gralnick H.R., Johnson R.E., Lee E.C., Lear A. Chronic granulocytic leukemia (CGL) during the course of chronic lymphocytic leukemia (CLL): correlation of blood, marrow, and spleen morphology and cytogenetics. Blood. 43:1974;333.
8. Hashimi L., Al-Katib A., Mertelsmann R., Mohamed A.N., Koziner B. Cytofluorometric detection of chronic myelocytic leukemia supervening in a patient with chronic lymphocytic leukemia. Am. J. Med. 80:1986;269.
9. Reeves J.E., Robbins B.A., Pankey L.R., Elias A.L., Anderson W.F. The simultaneous occurrence of variant hairy cell leukemia and chronic-phase chronic myelogenous leukemia. A case report. Cancer. 75:1995;2085.
10. 131I treatment of thyroid cancer - comments on the article 'second cancer following chemotherapy and radiotherapy - an epidemiological perspective' by J. Kaldor Acta Oncol. 31:1992;65.
11. Aguiar R.C. Therapy-related chronic myeloid leukemia: an epidemiological, clinical and pathogenetic appraisal. Leuk. Lymphoma. 29:1998;17.
12. Aguiar R.C., Beitler B., Dorlhiac-Llacer P.E., Chamone D.A. Secondary chronic myelogenous leukemia: a diverse pathogenesis? Acta Haematol. 92:1994;101.
13. Aguiar R.C., Sill H., Hochhaus A., Goldman J.M., Cross N.C. Molecular investigation of secondary chronic myeloid leukemia. Blood. 88:1996;2808.
14. Alfiar F., Amato D., Lipton J.H. Chronic myeloid leukemia in a woman with papillary carcinoma of the thyroid treated with radioactive iodine. Leuk. Lymphoma. 27:1997;365.
15. Armenta D., Cadotte M., Beaulieu R., Neemeh J., Long L., Pretty H., et al. Cytogenetic evidence of the splenic origin of chronic myeloid leukemia. Union Med. Can. 105:1976;922.
16. Auerbach H.E., Stelmach T., LaGuette J.G., Glick J.H., Kant J.A., Nowell P.C. Secondary Ph-positive CML with a minority monosomy 7 clone. Cancer Genet. Cytogenet. 28:1987;173.
17. Bauduer F., Ducout L., Dastugue N., Marolleau J.P. Chronic myeloid leukemia as a secondary neoplasm after anti-cancer radiotherapy: a report of three cases and a brief review of the literature. Leuk. Lymphoma. 43:2002;1057.
18. Beaty O. III, Hudson M.M., Greenwald C., Luo X., Fang L., Wilimas J.A., et al. Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease. J. Clin. Oncol. 13:1995;603.
19. Berman E., Strife A., Wisniewski D., Desai S., Gulati S., Jhanwar S., et al. Duration of the preclinical phase of chronic myelogenous leukemia: a case report. Blood. 78:1991;2969.
20. Berrebi A., Estrov Z., Chemke J. Chronic myeloid leukemia following radiotherapy for breast cancer. Isr. J. Med. Sci. 19:1983;653.
21. Blayney D.W., Longo D.L., Young R.C., Greene M.H., Hubbard S.M., Postal M.G., et al. Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease. N. Engl. J. Med. 316:1987;710.
22. Bouabdallah K., Marit G., Reiffers J., Broustet A., Bilhou-Nabera C., Wen Z.Q., et al. Hodgkin's disease and secondary Philadelphia chromosome positive chronic myelogenous leukemia. Cancer Genet. Cytogenet. 55:1991;277.
23. 131I treatment of thyroid carcinoma Br. J. Cancer. 28:1973;232.
24. Bundi R.S., Scott J.S., Halnan K.E. Chronic myeloid leukaemia following radioiodine therapy for carcinoma thyroid. Br. J. Radiol. 50:1977;61.
25. Carcassone Y., Gascard E. Leucémie myéloide succédant à une leucémie lymphoide. Marseille Méd. 105:1968;339.
26. Cazzola M., Bergamaschi G., Melazzini M., Ponchio L., Rosti V., Molinari E. Chronic myelogenous leukemia following radiotherapy and chemotherapy for non-Hodgkin lymphoma. Haematologica. 75:1990;77.
27. Chap L., Nimer S.D. Chronic myelogenous leukemia following repeated radiation therapy for histiocytosis X. Leuk. Lymphoma. 12:1994;315.
28. Dastugue N., Demur C., Pris F., Bugat R., Attal M., Bourrouillou G., et al. Association of the Philadelphia chromosome and 5q- in secondary blood disorder. Cancer Genet. Cytogenet. 30:1988;253.
29. Ezdinli E.Z., Sokal J.E., Aungst C.W., Kim U., Sandberg A.A. Myeloid leukemia in Hodgkin's disease: chromosomal abnormalities. Ann. Intern. Med. 71:1969;1097.
30. Haas O.A., Schwarzmeier J.D., Nacheva E., Fischer P., Paietta E. Investigations on karyotype evolution in patients with chronic myeloid leukemia (CML). Blut. 48:1984;33.
31. Haq A.U. Transformation of polycythemia vera to Ph-positive chronic myelogenous leukemia. Am. J. Hematol. 35:1990;110.
32. Hasegawa A., Ninomiya H., Yanagisawa K., Takada K., Hasegawa H., Hato T., et al. Successful treatment of combined interferon-alpha and hydroxycarbamide for chronic myelogenous leukemia following therapy for malignant lymphoma. Rinsho Ketsueki. 37:1996;853.
33. Hoppin E.C., Lewis J.P. Polycythemia rubra vera progressing to Ph1-positive chronic myelogenous leukemia. Ann. Intern. Med. 83:1975;820.
34. Hornsten P., Nordenson I., Wahlin A. Philadelphia chromosome negative acute lymphoblastic leukemia preceding Philadelphia positive chronic myelogenous leukemia. Cancer Genet. Cytogenet. 39:1989;147.
35. Hossfeld D.K. Chronic myelocytic leukemia: cytogenetic findings and their relations to pathogenesis and clinic. Ser. Haematol. 8:1975;53.
36. Hsiao H.H., Liu T.C., Chang C.S., Sue Y.C., Chen T.P., Lin S.F. Secondary chronic myelogenous leukemia after autologous peripheral blood stem cell transplantation for lymphoma. Int. J. Hematol. 73:2001;126.
37. Iurlo A., Foa P., Maiolo A.T., Polli E.E. Chronic myelogenous leukemia following radiation therapy for testicular seminoma. Blut. 59:1989;503.
38. Jackson G.H., Latham J.A., Lennard A.L., Taylor P.R., Proctor S.J. Rapid onset of chronic granulocytic leukaemia after treatment for Hodgkin's disease. Br. J. Haematol. 87:1994;193.
39. Johnson F.D., Jacobs E.M., Wood D.A. Hodgkin's disease terminating in chronic myeloid leukemia. Calif. Med. 104:1966;479.
40. Jones C.T. A case of chronic myeloid leukaemia in a patient previously treated with radiotherapy for localized reticulum cell sarcoma. Br. J. Radiol. 44:1971;801.
41. Kantarjian H.M., Keating M.J., Walters R.S., Smith T.L., Cork A., McCredie K.B., et al. Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features. J. Clin. Oncol. 4:1986;1748.
42. Khojasteh A., Perry M.C., Taylor H.M. Chronic myelocytic leukemia developing as a second cancer in a patient with chronic lymphocytic leukemia. CA Cancer J. Clin. 31:1981;172.
43. Koulischer L., Fruhling J., Henry J. Cytogenetic findings in Vaquez' disease. Eur. J. Cancer. 3:1967;193.
44. Leone G., Marra R., Pagano L., Storti S., Zollino M., Ricerca B.M., et al. Ph1-chromosome-positive chronic myelogenous leukemia following a 1-year off-therapy acute lymphoblastic leukemia. Oncology. 45:1988;389.
45. Majado M.J., Gonzalez Garcia C., Marin-Blazquez M.D., Morales Lazaro A., Moreno M. Appearance of a chronic myeloid leukemia in Waldenstrom's macroglobulinemia. Sangre. 37:1992;465.
46. Markman M. Chronic myelocytic leukemia as a secondary malignant condition in a patient receiving prolonged chemotherapy for ovarian carcinoma. West. J. Med. 143:1985;243.
47. Meadows A.T., Jarrett P. Pigmented nevi, Wilms tumor, and second malignant neoplasms. J. Pediatr. 93:1978;889.
48. Mele L., Pagano L., Equitani F., Chiusolo P., Rossi E., Zini G., et al. Lymphoid blastic crisis in Philadelphia chromosome-positive chronic granulocytic leukemia following high-grade non-Hodgkin's lymphoma: a case report and review of literature. Haematologica. 85:2000;544.
49. Moss T.J., Strauss L.C., Das L., Feig S.A. Secondary leukemia following successful treatment of Wilms' tumor. Am. J. Pediatr. Hematol. Oncol. 11:1989;158.
50. Nakamura H., Inokuchi K., Hanawa H., Yamaguchi H., Tamura H., Tajika K., et al. A case of chronic myeloid leukemia with minor bcr-abl transcript following fluorouracil therapy for esophageal carcinoma. Ann. Hematol. 79:2000;396.
51. Nanjangud G.J., Saikia T.K., Chopra H., Kadam P.R., Advani S.H. Development of Ph positive chronic myeloid leukemia in a patient with chronic lymphocytic leukemia treated with total body irradiation: a rare association. Leuk. Lymphoma. 22:1996;355.
52. 131I therapy for metastatic thyroid carcinoma Am. J. Roentgenol. Rad. Ther. Nucl. Med. 85:1961;914.
53. Pedersen-Bjergaard J., Brondum-Nielsen K., Karle H., Johansson B. Chemotherapy-related - late occurring - Philadelphia chromosome in AML, ALL and CML. Similar events related to treatment with DNA topoisomerase II inhibitors? Leukemia. 11:1997;1571.
54. Philip P., Pedersen-Bjergaard J. Cytogenetic, clinical, and cytologic characteristics of radiotherapy-related leukemias. Cancer Genet. Cytogenet. 31:1988;227.
55. Porta C., Casagranda I., Semino G., Moroni M., Ratto C. Chronic myeloid leukemia following cyclophosphamide-containing chemotherapy in a breast cancer patient. Haematologica. 78:1993;56.
56. Punt C.J., Rozenberg-Arska M., Verdonck L.F. Successful treatment with chemotherapy and subsequent allogeneic bone marrow transplantation for myeloid blastic crisis of chronic myelogenous leukemia following advanced Hodgkin's disease. Cancer. 60:1987;934.
57. Redman J.R., Vugrin D., Arlin Z.A., Gee T.S., Kempin S.J., Godbold J.H., et al. Leukemia following treatment of germ cell tumors in men. J. Clin. Oncol. 2:1984;1080.
58. Ritch P.S., Anderson T., Hanson G.A., Pisciotta A.V. Chronic granulocytic leukemia following radiation therapy for Hodgkin's disease. Cancer. 52:1983;462.
59. Robinson B.A., Colls B.M., Fitzharris B.M., Atkinson C.H. Second malignant neoplasms in patients with Hodgkin's disease. Aust. N. Z. J. Med. 24:1994;368.
60. Rosner F., Carey R.W., Zarrabi M.H. Breast cancer and acute leukemia: report of 24 cases and review of the literature. Am. J. Hematol. 4:1978;151.
61. Roth A.D., Oral A., Przepiorka D., Gollin S.M., Chervenick P.A. Chronic myelogenous leukemia and acute lymphoblastic leukemia occurring in the course of polycythemia vera. Am. J. Hematol. 43:1993;123.
62. Sakamaki H., Nakamura S., Maruyama Y., Nagata K., Yahara Y., Onozawa Y. Chronic myelocytic leukemia following chemotherapy of acute promyelocytic leukemia. Rinsho Ketsueki. 30:1989;1975.
63. Salvagno L., Soraru M., Leszl A., Koussis H., De Franchis G., Fiorentino M.V. Prolonged survival (17 years) in a patient with chronic myelogenous leukemia after therapy for Hodgkin's disease. Leuk. Lymphoma. 16:1994;177.
64. Schreiber Z.A., Axelrod M.R., Abebe L.S. Coexistence of chronic myelogenous leukemia and chronic lymphocytic leukemia. Cancer. 54:1984;697.
65. Schwartz A.D., Lee H., Baum E.S. Leukemia in children with Wilms tumor. J. Pediatr. 87:1975;374.
66. 131I treatment for thyroid carcinoma: a report of two cases and review of the literature Clin. Endocrinol. 43:1995;651.
67. Swaim W.R., Windschitl H.E., Doscherholmen A., Bankole R.O., Bates H.A. Chronic myelogenous leukemia in Hodgkin's disease: immunofluorescence of cells. Cancer. 27:1971;569.
68. Teichmann J.V., Sieber G., Ludwig W.D., Karow J., Ruehl H. Chronic myelocytic leukemia as a second neoplasia in the course of chronic lymphocytic leukemia. Case report and review of the literature. Leuk. Res. 10:1986;361.
69. Tester W.J., Kinsella T.J., Waller B., Makuch R.W., Kelley P.A., Glatstein E., et al. Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience. J. Clin. Oncol. 2:1984;762.
70. 131I therapy for metastatic thyroid carcinoma Taiwan I Hsueh Hui Tsa Chih. 83:1984;730.
71. Varady E., Deak B., Molnar Z.S., Rosta A., Schneider T., Esik O., et al. Second malignancies after treatment for Hodgkin's disease. Leuk. Lymphoma. 42:2001;1275.
72. Verhoef G.E., Demuynck H., Stul M.S., Cassiman J.J., Mecucci C., Van Den Berghe H., et al. Philadelphia chromosome-positive chronic myelogenous leukemia in treated Hodgkin's disease. Cancer Genet. Cytogenet. 49:1990;171.
73. 131I for thyroid carcinoma. Report of a case and review of the literature Cancer Genet. Cytogenet. 55:1991;217.
74. Waller C.F., Fetscher S., Lange W. Secondary chronic myelogenous leukemia after chemotherapy followed by adjuvant radiotherapy for small cell lung cancer. Leuk. Res. 23:1999;961.
75. Burns E.A., Leventhal E.A. Aging, immunity, and cancer. Cancer Control. 7:2000;513.
76. Ginaldi L., De Martinis M., D'Ostilio A., Marini L., Loreto M.F., Corsi M.P., et al. Cell proliferation and apoptosis in the immune system in the elderly. Immunol. Res. 21:2000;31.
77. Sanz L., Cervantes F., Esteve J., Vilardell J., Marin P., Rozman C., et al. Chronic myeloid leukemia after renal transplantation: a report of a case and review of the literature. Sangre. 41:1996;391.
78. Au W.Y., Klasa R.J., Gallagher R., Le N., Gascoyne R.D., Connors J.M. Second malignancies in patients with hairy cell leukemia in British Columbia: a 20-year experience. Blood. 92:1998;1160.
79. Sokal J., Cox E., Baccarani M. Prognostic discrimination in good risk chronic granulocytic leukemia. Blood. 63:1984;1352.
80. Hasford J., Pfirrmann M., Hehlmann R., Allan N.C., Baccarani M., Kluin-Nelemans J.C., et al. A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alpha. J. Natl. Cancer Inst. 90:1998;850.
81. Storlazzi C.T., Specchia G., Anelli L., Albano F., Pastore D., Zagaria A., et al. Breakpoint Characterization of der(9) deletions in CML patients. Genes Chromosomes Cancer. 35:2002;271-276.